Form 8-K - Current report:
SEC Accession No. 0001171843-25-002572
Filing Date
2025-04-29
Accepted
2025-04-29 07:45:32
Documents
15
Period of Report
2025-04-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_042825.htm   iXBRL 8-K 15195
2 PRESS RELEASE exh_991.htm EX-99.1 12845
  Complete submission text file 0001171843-25-002572.txt   232297

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE gnw-20190101.xsd EX-101.SCH 3003
4 XBRL DEFINITION FILE gnw-20190101_def.xml EX-101.DEF 25598
5 XBRL LABEL FILE gnw-20190101_lab.xml EX-101.LAB 34011
6 XBRL PRESENTATION FILE gnw-20190101_pre.xml EX-101.PRE 22139
18 EXTRACTED XBRL INSTANCE DOCUMENT f8k_042825_htm.xml XML 3273
Mailing Address 2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA A6 L4W 5K5
Business Address 2400 SKYMARK AVENUE, UNIT 6 MISSISSAUGA A6 L4W 5K5 647-476-1350
Profound Medical Corp. (Filer) CIK: 0001628808 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39032 | Film No.: 25882708
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)